Barclays analyst Manav Patnaik lowered the firm’s price target on Equifax (EFX) to $215 from $240 and keeps an Equal Weight rating on the shares. The company’s Q4 revenue beat but margins missed estimates, the analyst tells investors in a research note. Barclays says Equifax’s guidance and new FICO disclosures “provide much needed clarity.”
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EFX:
- Equifax price target lowered to $200 from $242 at Clear Street
- Equifax: Strong Q4 Beat, Rebounding Government Segment, and Undervalued Long-Term Earnings Power Support Buy Rating
- Gen Digital, Equifax announced expanded partnership
- Morgan Stanley axes Equifax price target, say enduring EPS growth not priced in
- Morning Movers: Eli Lilly rises, Boston Scientific falls after quarterly results
